Philip J. Young
2013 - AmpliPhi Biosciences
In 2013, Philip J. Young earned a total compensation of $2.4M as President and CEO and Director at AmpliPhi Biosciences, a 18% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,856,000 |
|---|---|
| Salary | $400,000 |
| Other | $105,396 |
| Total | $2,361,396 |
Young received $1.9M in option awards, accounting for 79% of the total pay in 2013.
Young also received $400K in salary and $105.4K in other compensation.
Rankings
In 2013, Philip J. Young's compensation ranked 3,315th out of 12,286 executives tracked by ExecPay. In other words, Young earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,315 out of 12,286 | 73rd |
Division Manufacturing | 1,126 out of 4,612 | 76th |
Major group Chemicals And Allied Products | 298 out of 1,462 | 80th |
Industry group Drugs | 204 out of 1,156 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 28 out of 196 | 86th |
Source: SEC filing on April 30, 2014.
Young's colleagues
We found two more compensation records of executives who worked with Philip J. Young at AmpliPhi Biosciences in 2013.